CDCA8与肿瘤发生发展及干细胞干性维持的关系

国际肿瘤学杂志››2021,Vol. 48››Issue (4): 216-219.doi:10.3760/cma.j.cn371439-20201012-00043

CDCA8与肿瘤发生发展及干细胞干性维持的关系

魏永健¹, 胡进静², 李汛^1,^2,³()

¹兰州大学第一临床医学院 730000
²甘肃省生物治疗与再生医学重点实验室,兰州730000
³兰州大学第一医院普外科兰州大学医学院肿瘤防治中心甘肃省肝胆胰外科研究所,兰州 730000

收稿日期:2020-10-12修回日期:2020-12-25出版日期:2021-04-08发布日期:2021-06-18
通讯作者:李汛 E-mail:lxdr21@126.com
基金资助:
国家自然科学基金(31570509);甘肃省科技计划(18JR2TA018);甘肃省科技重大专项(1602FKDA001);甘肃省高等学校创新能力提升项目(2019B-003);兰州大学“中央高校基本科研业务费专项资金”项目(lzujbky-2019-kb21);兰州大学“中央高校基本科研业务费专项资金”项目(lzujbky-2020-kb22)

Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells

Wei Yongjian¹, Hu Jinjing², Li Xun^1,^2,³()

¹First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China
²Gansu Provincial Key Laboratory of Biological Therapy and Regenerative Medicine Transformation, Lanzhou 730000, China
³Department of General Surgery, First Hospital of Lanzhou University, Medical College of Lanzhou University Trauma Prevention and Treatment Center, Gansu Provincial Research Institute of Hepato-Pancreato-Biliary Surgery, Lanzhou 730000, China

Received:2020-10-12Revised:2020-12-25Online:2021-04-08Published:2021-06-18
Contact:Li Xun E-mail:lxdr21@126.com
Supported by:
National Natural Science Foundation of China(31570509);Gansu Provincial Science and Technology Plan Project of China(18JR2TA018);Gansu Provincial Major Science and Technology Project of China(1602FKDA001);Gansu Provincial Innovation Capability Improvement Project of Colleges and Universities(2019B-003);"Central Universities Basic Scientific Research Service Fees" of Lanzhou University(lzujbky-2019-kb21);"Central Universities Basic Scientific Research Service Fees" of Lanzhou University(lzujbky-2020-kb22)

摘要/Abstract

摘要：

细胞分裂周期相关基因8(CDCA8)参与细胞分裂周期的准确调控,其表达的改变可影响多种肿瘤的发生发展及患者预后。近年来研究发现,CDCA8可能在肿瘤干细胞的干性维持中起重要作用。探索CDCA8影响肿瘤的相关机制对于肿瘤的诊治具有十分重要的意义。

魏永健, 胡进静, 李汛. CDCA8与肿瘤发生发展及干细胞干性维持的关系[J]. 国际肿瘤学杂志, 2021, 48(4): 216-219.

Wei Yongjian, Hu Jinjing, Li Xun. Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells[J]. Journal of International Oncology, 2021, 48(4): 216-219.

参考文献28

[1]	Pan S, Zhan Y, Chen X, et al. Identification of biomarkers for controlling cancer stem cell characteristics in bladder cancer by network analysis of transcriptome data stemness indices[J]. Front Oncol, 2019, 9:613. DOI: 10.3389/fonc.2019.00613. doi:10.3389/fonc.2019.00613
[2]	Phan NN, Wang CY, Li KL, et al. Distinct expression of CDCA3, CDCA5, and CDCA 8 leads to shorter relapse free survival in breast cancer patient[J]. Oncotarget, 2018, 9(6):6977-6992. DOI: 10.18632/oncotarget.24059. doi:10.18632/oncotarget.v9i6
[3]	Yu D, Shi L, Bu Y, et al. Cell division cycle associated 8 is a key regulator of tamoxifen resistance in breast cancer[J]. J Breast Cancer, 2019, 22(2):237-247. DOI: 10.4048/jbc.2019.22.e29. doi:10.4048/jbc.2019.22.e29
[4]	张路遥, 黄辉星, 曹立环, 等. CDCA8和INCENP mRNA在肝细胞癌组织中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2017, 24(2):158-167. DOI: 10.3872/j.issn.1007-385X.2017.02.010.
[5]	Bi Y, Chen S, Jiang J, et al. CDCA8 expression and its clinical relevance in patients with bladder cancer[J]. Medicine (Baltimore), 2018, 97(34): e11899. DOI: 10.1097/MD.0000000000011899. doi:10.1097/MD.0000000000011899
[6]	Gao X, Wen X, He H, et al. Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells[J]. Peer J, 2020, 8:e9078. DOI: 10.7717/peerj.9078. doi:10.7717/peerj.9078
[7]	Dai C, Miao CX, Xu XM, et al. Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells[J]. J Biol Chem, 2015, 290(37):22423-22434. DOI: 10.1074/jbc.M115.642710. doi:10.1074/jbc.M115.642710
[8]	Fu G, Xu Z, Chen X, et al. CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation[J]. J Cancer, 2020, 11(9):2408-2420. DOI: 10.7150/jca.35372. doi:10.7150/jca.35372
[9]	Bu Y, Shi L, Yu D, et al. CDCA 8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells[J]. Gene, 2019, 703:1-6. DOI: 10.1016/j.gene.2019.04.006. doi:10.1016/j.gene.2019.04.006
[10]	Chang JL, Chen TH, Wang CF, et al. Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer[J]. Exp Cell Res, 2006, 312(7):962-973. DOI: 10.1016/j.yexcr.2005.12.015. doi:10.1016/j.yexcr.2005.12.015
[11]	Date DA, Jacob CJ, Bekier ME, et al. Borealin is repressed in response to p53/Rb signaling[J]. Cell Biol Int, 2007, 31(12):1470-1481. DOI: 10.1016/j.cellbi.2007.06.013. doi:10.1016/j.cellbi.2007.06.013
[12]	Hindriksen S, Lens SMA, Hadders MA. The ins and outs of aurora B inner centromere localization[J]. Front Cell Dev Biol, 2017, 5:112. DOI: 10.3389/fcell.2017.00112. doi:10.3389/fcell.2017.00112pmid:29312936
[13]	Jiao DC, Lu ZD, Qiao JH, et al. Expression of CDCA8 correlates closely with FOXM1 in breast cancer: public microarray data analysis and immunohistochemical study[J]. Neoplasma, 2015, 62(3):464-469. DOI: 10.4149/neo_2015_055. doi:10.4149/neo_2015_055pmid:25866227
[14]	Hélias-Rodzewicz Z, Lourenco N, Bakari M, et al. CDKN2A depletion causes aneuploidy and enhances cell proliferation in non-immortalized normal human cells[J]. Cancer Invest, 2018, 36(6):338-348. DOI: 10.1080/07357907.2018.1491588. doi:10.1080/07357907.2018.1491588
[15]	Bi N, Sun Y, Lei S, et al. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol associated hepatocellular carcinoma using weighted gene co expression network analysis[J]. Oncol Rep, 2020, 44(2):611-627. DOI: 10.3892/or.2020.7634. doi:10.3892/or
[16]	Wang X, Song P, Huang C, et al. Weighted gene co expression network analysis for identifying hub genes in association with prognosis in Wilms tumor[J]. Mol Med Rep, 2019, 19(3):2041-2050. DOI: 10.3892/mmr.2019.9881.
[17]	Wei W, Lv Y, Gan Z, et al. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma[J]. Oncol Lett, 2019, 17(5):4321-4328. DOI: 10.3892/ol.2019.10130.
[18]	Xu N, Chen SH, Lin TT, et al. Development and validation of hub genes for lymph node metastasis in patients with prostate cancer[J]. J Cell Mol Med, 2020, 24(8):4402-4414. DOI: 10.1111/jcmm.15098. doi:10.1111/jcmm.v24.8
[19]	Song Z, Huang Y, Zhao Y, et al. The identification of potential biomarkers and biological pathways in prostate cancer[J]. J Cancer, 2019, 10(6):1398-1408. DOI: 10.7150/jca.29571. doi:10.7150/jca.29571
[20]	Ci C, Tang B, Lyu D, et al. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis[J]. Int J Mol Med, 2019, 43(1):404-412. DOI: 10.3892/ijmm.2018.3985.
[21]	Yue L, Li L, Li D, et al. High-throughput screening for Survivin and Borealin interaction inhibitors in hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 2017, 484(3):642-647. DOI: 10.1016/j.bbrc.2017.01.160. doi:10.1016/j.bbrc.2017.01.160
[22]	Li B, Liu B, Zhang X, et al. KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8[J]. J Cell Physiol, 2020, 235(5):4227-4238. DOI: 10.1002/jcp.29201. doi:10.1002/jcp.v235.5
[23]	Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy[J]. J Cell Physiol, 2019, 234(6):8381-8395. DOI: 10.1002/jcp.27740. doi:10.1002/jcp.v234.6
[24]	徐贺龙, 李燕, 任程晖, 等. 利用加权基因共表网络识别肝细胞癌干细胞相关基因的研究[J]. 中国普外基础与临床杂志, 2020, 27(5):560-568. DOI: 10.7507/1007-9424.202001067.
[25]	Zhao M, Chen Z, Zheng Y, et al. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis[J]. J Cancer Res Clin Oncol, 2020, 146(6):1463-1472. DOI: 10.1007/s00432-020-03194-x. doi:10.1007/s00432-020-03194-x
[26]	Li W, Lee MR, Choi E, et al. Clinicopathologic significance of survivin expression in relation to CD133 expression in surgically resected stage Ⅱ or Ⅲ colorectal cancer[J]. J Pathol Transl Med, 2017, 51(1):17-23. DOI: 10.4132/jptm.2016.09.23. doi:10.4132/jptm.2016.09.23
[27]	Comisso E, Scarola M, Rosso M, et al. OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness[J]. Oncogene, 2017, 36(30):4253-4266. DOI: 10.1038/onc.2017.20. doi:10.1038/onc.2017.20pmid:28319064
[28]	Ding H, Wang Y, Zhang H. CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-fluorouracil resis-tance in hepatocellular carcinoma[J]. J Pharmacol Sci, 2020, 143(3):219-225. DOI: 10.1016/j.jphs.2020.04.006. doi:10.1016/j.jphs.2020.04.006

CDCA8与肿瘤发生发展及干细胞干性维持的关系

Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献28

相关文章15

编辑推荐

Metrics

本文评价

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.